Market Tracker

05/27 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

11.14
Delayed Data
As of May 27
 +0.24 / +2.20%
Today’s Change
7.86
Today|||52-Week Range
25.56
-24.93%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close10.90
Today’s open10.93
Day’s range10.81 - 11.15
Volume259,345
Average volume (3 months)605,635
Market cap$790.0M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+0.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...-0.08-0.75%
RLYPRelypsa Inc+1.46+8.80%
CHRSCoherus BioSciences ...-0.05-0.28%
ADAPAdaptimmune Therapeu...-0.15-1.50%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts